Obesity Treatment to Improve Diabetes

NCT05390307 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Liraglutide / Semaglutide
DRUG: Dapagliflozin
DRUG: Liraglutide or Semaglutide / Dapagliflozin
DRUG: Liraglutide or Semaglutide / Dapagliflozin plus intensive weight loss nutrition
OTHER: Usual care

Sponsor

Dasman Diabetes Institute